Menu
GeneBe

rs1801116

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000395.3(CSF2RB):c.2400G>A(p.Pro800=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0279 in 1,614,078 control chromosomes in the GnomAD database, including 710 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 44 hom., cov: 32)
Exomes 𝑓: 0.028 ( 666 hom. )

Consequence

CSF2RB
NM_000395.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.287
Variant links:
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 22-36938208-G-A is Benign according to our data. Variant chr22-36938208-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 226552.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.287 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0231 (3514/152224) while in subpopulation NFE AF= 0.0282 (1917/67990). AF 95% confidence interval is 0.0271. There are 44 homozygotes in gnomad4. There are 1683 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 44 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CSF2RBNM_000395.3 linkuse as main transcriptc.2400G>A p.Pro800= synonymous_variant 14/14 ENST00000403662.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CSF2RBENST00000403662.8 linkuse as main transcriptc.2400G>A p.Pro800= synonymous_variant 14/145 NM_000395.3 P1P32927-1
CSF2RBENST00000406230.5 linkuse as main transcriptc.2418G>A p.Pro806= synonymous_variant 13/131 P32927-2

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3512
AN:
152106
Hom.:
44
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0164
Gnomad AMI
AF:
0.0537
Gnomad AMR
AF:
0.0202
Gnomad ASJ
AF:
0.0337
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.0230
Gnomad FIN
AF:
0.0245
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0282
Gnomad OTH
AF:
0.0263
GnomAD3 exomes
AF:
0.0229
AC:
5758
AN:
251372
Hom.:
89
AF XY:
0.0236
AC XY:
3201
AN XY:
135864
show subpopulations
Gnomad AFR exome
AF:
0.0169
Gnomad AMR exome
AF:
0.0113
Gnomad ASJ exome
AF:
0.0309
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0219
Gnomad FIN exome
AF:
0.0272
Gnomad NFE exome
AF:
0.0294
Gnomad OTH exome
AF:
0.0299
GnomAD4 exome
AF:
0.0284
AC:
41549
AN:
1461854
Hom.:
666
Cov.:
35
AF XY:
0.0284
AC XY:
20685
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.0162
Gnomad4 AMR exome
AF:
0.0111
Gnomad4 ASJ exome
AF:
0.0332
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0230
Gnomad4 FIN exome
AF:
0.0280
Gnomad4 NFE exome
AF:
0.0308
Gnomad4 OTH exome
AF:
0.0260
GnomAD4 genome
AF:
0.0231
AC:
3514
AN:
152224
Hom.:
44
Cov.:
32
AF XY:
0.0226
AC XY:
1683
AN XY:
74422
show subpopulations
Gnomad4 AFR
AF:
0.0164
Gnomad4 AMR
AF:
0.0202
Gnomad4 ASJ
AF:
0.0337
Gnomad4 EAS
AF:
0.000388
Gnomad4 SAS
AF:
0.0232
Gnomad4 FIN
AF:
0.0245
Gnomad4 NFE
AF:
0.0282
Gnomad4 OTH
AF:
0.0260
Alfa
AF:
0.0275
Hom.:
31
Bravo
AF:
0.0220
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.0293
EpiControl
AF:
0.0291

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 04, 2020- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Pro800Pro in exon 14 of CSF2RB: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 2.8% (245/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs1801116). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
Cadd
Benign
5.5
Dann
Benign
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1801116; hg19: chr22-37334250; API